Margie L. Clapper

Fox Chase Cancer Center

NIH Rank #7524
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#7,524
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.6M across 5 grants · National rank #7524.

Top grants by award amount

Margie L. Clapper's NIH grant portfolio, ranked by award amount.

  • 5R01CA262551-03R01
    Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis
    $525.7K
    award amount
  • 75N91019D00022-P00001-759102200001-2N01
    BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
    $515.6K
    award amount
  • 5U54CA272686-03U54
    Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
    $397.1K
    award amount
  • 3U54CA272686-03S1U54
    Novel small molecule agents to correct pathogenic VHL missense mutations
    $200K
    award amount
  • 75N91024D00003-0-759102400001-1N01
    TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENT Base IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate E
    $3.5K
    award amount

Affiliation

Institutions that have administered grants for Margie L. Clapper.

Affiliated with Fox Chase Cancer Center (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fox Chase Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7524